Clinical Trials Browser

Phase 2 × DMMR Colorectal Cancer × Surgical Procedures, Operative × Clear all

NCT06262581 2024-02-16

Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery

Phase 2 Unknown

GastrointestinalOther solid neoplasm

DMMR Colorectal Cancer